Dr. Andreas Eckert is the founder and Chairman of the Supervisory Board of Eckert & Ziegler SE, a global leader in isotope technology for medical, scientific, and industrial applications. He led the company as Executive Board Chairman until 2023 and now focuses on strategic oversight. In addition to his role at Eckert & Ziegler, he has founded several life science ventures, including Eckert Life Science Accelerator GmbH, and holds supervisory roles in biotech firms such as Glycotope and Pentixapharm.